ANAB (AnaptysBio, Inc.) Forward P/E Multiple
Compliance with environmental regulations and the filtration of laboratory emissions impact costs, as evidenced by the forward P/E of AnaptysBio, Inc. (ANAB) on the current GURU.Markets platform chart, where 0.00 becomes the new value for this metric. Patents and FDA tests serve as business protections, while capital is safeguarded by partner payments for the transfer of antibody rights, eliminating price wars.
Analytical breakdowns for AnaptysBio, Inc.
- current price and projected stock value:
- business market valuation indicators:
- book capitalization information:
- debt and liquidity details:
- company profitability and valuation multiples indicators:
ANAB - Company Profit|Projected Future Earnings AnaptysBio, Inc.|ANAB - P/E Multiple|Future Price to Earnings AnaptysBio Corp|ANAB - Market Cap to Earnings and Growth Ratio|Enterprise Value to EBITDA Ratio AnaptysBio Inc|ANAB - Company profit before taxes, interest and amortization|Net earnings per share for the last 12 months AnaptysBio|ANAB - Net earnings per one share for the last twelve months|Year-over-year earnings per share growth for the last twelve months anaptysbio.com|ANAB - Expected net earnings per share growth this year|Earnings growth forecast for next year AnaptysBio, Inc.
Summary company analytics:AnaptysBio
AnaptysBio, Inc. (ANAB) fully delegates production and testing to external partners, making its capitalization dependent on external risks. The company's forward P/E ratio compares the current market price with projected earnings, stripping the valuation of time lags. The dynamics of this indicator reveal phases of unjustified investor optimism or panic. Analyzing the curve allows for the determination of the business's fair value relative to expected earnings. This is critically important for assessing the reliability of an asset with an absolute dependence on outsourcing.
Competitors of AnaptysBio, Inc. (ANAB)
Projected Price to Earnings ARGX (argenx)|BNTX (BioNTech Inc.) - Future Price to Earnings Multiple|Forward P/E Multiple ABVX (abivax.com)|Market Cap to Projected Earnings ADMA Corp (ADMA)|PTGX - Future Price to Earnings|immunovant.com (IMVT) - Projected Price to Earnings|Kiniksa (KNSA) - Future Price to Earnings|Projected Price to Earnings Grifols SA|Projected Price to Earnings ADPT|Forward P/E Multiple Celldex Corp|Future Price to Earnings Aurinia Pharmaceuticals (AUPH)|biocryst.com - Price to Future Earnings Ratio|Forward P/E Multiple VERA (Vera Therapeutics)|Dianthus Therapeutics Inc (DNTH) - Projected Price to Earnings Ratio|Pharvaris Corp - Forward P/E Multiple|ABCL - Forward P/E Multiple|Tourmaline Bio, Inc. (TRML) - Future Price to Earnings|Price to Future Earnings Ratio PGEN|PHAR (Pharming Group) - Forward P/E Multiple|Forward P/E Multiple Nektar Therapeutics Inc|Future Price to Earnings Upstream Bio Corp (UPB)|ZBIO: Price to Expected Earnings Ratio|Immunome, Inc. - Projected Price to Earnings|Market Cap to Future Earnings Ratio GOSS (gossamerbio.com)|KALV: Projected Price to Earnings|Projected Price to Earnings Ratio Septerna, Inc.|Pieris Pharmaceuticals Inc (PVLA) - Future Price to Earnings|SVRA - Market Cap to Projected Earnings|RIGL (Rigel Pharmaceuticals) - Forward P/E Multiple|Future Price to Earnings ATXS|Forward P/E Multiple ENGN|Market Cap to Projected Earnings RAPT Therapeutics Inc.|Future Price to Earnings Aerovate Therapeutics JBIO|Aclaris Therapeutics, Inc (ACRS) - Projected Price to Earnings Ratio|KYTX: Projected Price to Earnings|Future Price to Earnings Multiple TLSA (tizianalifesciences.com)|CABA: Forward P/E Multiple|VTYX - Market Cap to Projected Earnings|Future Price to Earnings Theratechnologies Inc|Price to Future Earnings Ratio AVTX (Avalo Therapeutics Inc)|Forward P/E Multiple ELDN|Projected Price to Earnings agenusbio.com AGEN|Climb Bio - Projected Price to Earnings|Market Cap to Projected Earnings Zura Bio Ltd (ZURA)|aTyr - Forward P/E Multiple|ADAG - Forward P/E Multiple|ikenaoncology.com (IMA) - Future Price to Earnings|Price to Future Earnings Ratio STTK|EQ (Equillium Inc) - Forward P/E Multiple|Forward P/E Multiple Connect Pharma|Forward P/E Multiple IMUX|Future Price to Earnings ATRA (atarabio.com)|Future Price to Earnings InflaRx IFRX|XFOR (x4pharma.com) - Price to Expected Earnings Ratio|Adicet - Forward P/E Multiple|Future Price to Earnings Multiple CELU (Celularity Inc.)|INMB: Forward P/E Multiple|Barinthus Biotherapeutics Corp (BRNS) - Forward P/E Multiple|Future Price to Earnings Kezar Life Sciences|SABS: Future Price to Earnings Multiple|Future Price to Earnings Akari Therapeutics Plc (AKTX)|Projected Price to Earnings enlivex.com ENLV|Forward P/E Multiple QTTB (Q32 Bio)|Forward P/E Multiple GeoVax Corp GOVX|EDSA: Projected Price to Earnings|Future Price to Earnings Multiple IBIO (ibioinc.com)|CARM: Forward P/E Multiple|XTLB - Market Cap to Projected Earnings|Future Price to Earnings Bolt Biotherapeutics Inc.|Projected Price to Earnings HCW Biologics Inc (HCWB)|Future Price to Earnings Aptevo Therapeutics (APVO)|Projected Price to Earnings AIM ImmunoTech, Inc. AIM|Aditxt, Inc. - Projected Price to Earnings|Forward P/E Multiple GRI Bio Inc GRI|XRTX - Future Price to Earnings|HIND (Vyome Therapeutics) - Price to Future Earnings Ratio|REVB: Forward P/E Multiple|Projected Price to Earnings Ratio indaptusrx.com (INDP)|SCNI (Scinai Immunotherapeutics Ltd.) - Forward P/E Multiple|Forward P/E Multiple CalciMedica Corp|Future Price to Earnings Affimed (AFMD)|allakos.com - Price to Future Earnings Ratio|Forward P/E Multiple HOOK (HOOKIPA Pharma)|Forward P/E Multiple IGM Biosciences Inc. IGMS|ITOS - Future Price to Earnings|Price to Expected Earnings Ratio OCEA|TCBP (TC BioPharm (Holdings) PLC) - Projected Price to Earnings|THRD: Market Cap to Future Earnings Ratio
